Pharmaceutical intermediates refer to some chemical raw materials or products used in the process of pharmaceutical synthesis. According to the industry, pharmaceutical intermediates industry as an important field of fine chemical industry, there will be a greater space for development in the future.
From the development history of pharmaceutical intermediates industry in China, after nearly 30 years of development, pharmaceutical intermediates have developed from a small branch of the chemical industry into an emerging industry with an output value of billions of yuan, and the market competition is increasingly fierce.
It is understood that in the early stage of the development of pharmaceutical intermediates industry, due to small investment and high rate of return, pharmaceutical intermediates enterprises mushroomed, especially in Zhejiang, Taizhou, Nanjing and other areas with favorable conditions for the development of pharmaceutical intermediates, especially rapid development. At present, as the change of medical market pattern, as well as the production of new drugs on the market is limited, the difficulty of pharmaceutical intermediates industry new product development is more and more big, the traditional product is becoming more and more fierce competition, pharmaceutical intermediates industry profits fell rapidly, and pharmaceutical intermediates become a have to think about the problem of how the development of an enterprise.
The industry believes that it may be possible to form its own competitive advantages from technology, influence, transformation and other aspects, so as to stand out in the market.
In technology, it mainly refers to improving technology and saving cost. It is reported that the process route of pharmaceutical intermediates is long, the reaction steps are many, the amount of solvent is large, and the potential for technical improvement is large.
In terms of influence, it mainly forms its own characteristic products and improves its influence in the industry. It is understood that due to China's pharmaceutical intermediates industry, product homogenization competition is serious, if the enterprise can create their own advantage products, will be able to occupy more advantages in the market.
In terms of transformation, at present, with the stricter requirements of domestic environmental protection, resources are inclined to high value-added industries, and with the increase of environmental protection costs, transformation has become a sustainable development of pharmaceutical intermediates enterprises have to think about.
Shanghai Massive Chemical Technology Co., Ltd. is engaged in development, production and marketing Specialty Chemicals to satisfy the changing needs of the chemical industry. We specialize in manufacturing high quality of Advanced Intermediates, Special Fine chemicals, synthesis of novel and known molecular compounds, have substantial experience in process development, scale up and commercialization.
Nowadays, more areas are developed by shareholding and contract manufacturing, to find the application in wide range viz. pharmaceuticals, crop protection, animal & human nutrition, flavor & fragrances, personal care, paints & coatings, also doing custom research and manufacturing for pharmaceutical and agrochemical customers on exclusive basis.
Reg Office: Room 435, Building 9, No.2568 Gudai Road, Minhang District, Shanghai, China.
Pilot Lab: Building 1, No. 589 Qinling Street, Shijiazhuang High-tech Zone,Hebei, China.
Plant Unit 1: Xincheng town clean chemical park, Xinji, Hebei, China.
Plant Unit 2: Dongming County South Chemical Park, Heze City, China.
Tel: +86-21-34943721
Email:Massive@massivechem.com
Info@massivechem.com
Shanghai Massive Chemical Technology Co., Ltd. All Rights Reserved(C)2023 Supported by Record number:沪ICP备18008139号